Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,694,136 papers from all fields of science
Search
Sign In
Create Free Account
Renal Cell Carcinoma
Known as:
Adenocarcinoma of the Kidney
, Carcinoma, Renal Cell [Disease/Finding]
, rccs
Expand
A carcinoma arising from the renal parenchyma. There is a strong correlation between cigarette smoking and the development of renal cell carcinoma…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
49 relations
Aldesleukin
Blood supply aspects
CDISC SEND Tumor Findings Results Terminology
CISH gene
Expand
Broader (4)
Carcinoma
Kidney Neoplasm
Neoplasms
Renal carcinoma
Narrower (4)
Chromophobe Renal Cell Carcinoma
Clear-cell metastatic renal cell carcinoma
Collecting Duct Carcinoma of the Kidney
Thyroid Carcinoma, Papillary, With Papillary Renal Neoplasia
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2019
Highly Cited
2019
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal‐Cell Carcinoma
B. Rini
,
E. Plimack
,
+24 authors
T. Powles
The New England journal of medicine
2019
Corpus ID: 205103608
BACKGROUND The combination of pembrolizumab and axitinib showed antitumor activity in a phase 1b trial involving patients with…
Expand
Review
2010
Review
2010
Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial.
C. Sternberg
,
I. Davis
,
+13 authors
R. Hawkins
Journal of clinical oncology : official journal…
2010
Corpus ID: 9515491
PURPOSE Pazopanib is an oral angiogenesis inhibitor targeting vascular endothelial growth factor receptor, platelet-derived…
Expand
Highly Cited
2010
Highly Cited
2010
Phase 3 trial of everolimus for metastatic renal cell carcinoma
R. Motzer
,
B. Escudier
,
+9 authors
A. Ravaud
Cancer
2010
Corpus ID: 13311871
A phase 3 trial demonstrated superiority at interim analysis for everolimus over placebo in patients with metastatic renal cell…
Expand
Highly Cited
2009
Highly Cited
2009
Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma.
R. Motzer
,
Thomas E. Hutson
,
+16 authors
R. Figlin
Journal of clinical oncology : official journal…
2009
Corpus ID: 7675933
PURPOSE A randomized, phase III trial demonstrated superiority of sunitinib over interferon alfa (IFN-alpha) in progression-free…
Expand
Highly Cited
2006
Highly Cited
2006
Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma.
R. Motzer
,
M. Michaelson
,
+12 authors
B. Rini
Journal of clinical oncology : official journal…
2006
Corpus ID: 43889851
PURPOSE Renal cell carcinoma (RCC) is characterized by loss of von Hippel Lindau tumor suppressor gene activity, resulting in…
Expand
Highly Cited
2002
Highly Cited
2002
Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma.
R. Motzer
,
J. Bacik
,
B. Murphy
,
P. Russo
,
M. Mazumdar
Journal of clinical oncology : official journal…
2002
Corpus ID: 482830
PURPOSE To define outcome data and prognostic criteria for patients with metastatic renal cell carcinoma (RCC) treated with…
Expand
Highly Cited
1999
Highly Cited
1999
Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.
R. Motzer
,
M. Mazumdar
,
J. Bacik
,
W. Berg
,
A. Amsterdam
,
J. Ferrara
Journal of clinical oncology : official journal…
1999
Corpus ID: 20603868
PURPOSE To identify prognostic factors and a model predictive for survival in patients with metastatic renal-cell carcinoma (RCC…
Expand
Review
1999
Review
1999
Rising incidence of renal cell cancer in the United States.
W. Chow
,
S. Devesa
,
J. Warren
,
J. Fraumeni
JAMA
1999
Corpus ID: 39178106
CONTEXT Clinical surveys have revealed that incidental detection of renal cell carcinoma is rising because of increased use of…
Expand
Highly Cited
1994
Highly Cited
1994
Mutations of the VHL tumour suppressor gene in renal carcinoma
J. Gnarra
,
K. Tory
,
+21 authors
W. Linehan
Nature Genetics
1994
Corpus ID: 39518223
Multiple, bilateral renal carcinomas are a frequent occurrence in von Hippel–Lindau (VHL) disease. To elucidate the aetiological…
Expand
Highly Cited
1956
Highly Cited
1956
Renal cell carcinoma.
M. Karno
Bulletin. Tufts-New England Medical Center
1956
Corpus ID: 150947
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE